Dr Nissen discusses the impetus behind the study, the potential public health implications of the results, and more.
The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.
Your daily dose of the clinical news you may have missed.
Cologuard Plus bests previous iteration and demonstrates greater sensitivity and specificity for any CRC relative to fecal immunochemical tests.
Findings from the ECLIPSE clinical trial showed the blood-based cancer screening test detects 83% of people with CRC, with a specificity of 90%.
A CPT code for time spent petitioning insurance companies to approve patient prescriptions has been proposed before; sentiment was not unanimous.
One study showed a significant 1.5% decrease in HbA1c 6 months after participants taking a GLP-1 RA started using the Freestyle Libre system.
The Dexcom system is for adults over the age of 18 years who do not use insulin, such as individuals with T2D who use oral medications, a US population of 25 million.
The digital prescription therapeutic when used along with prescription diabetes therapies, can help reduce the costs of managing the disease and enhance standard of care.
Beware the potential pitfalls of telemedicine, from privacy concerns to patient confusion, says associate general counsel for The Doctors Company.